[An anti-Covid-19 lentiviral vaccine candidate that can be administered by the nasal route]
Med Sci (Paris)
.
2021 Dec;37(12):1172-1175.
doi: 10.1051/medsci/2021173.
Epub 2021 Dec 20.
[Article in French]
Authors
Laleh Majlessi
1
,
Pierre Charneau
1
Affiliation
1
Laboratoire Commun Pasteur-TheraVectys, Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France.
PMID:
34928223
DOI:
10.1051/medsci/2021173
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Administration, Intranasal
COVID-19 Vaccines / administration & dosage*
Humans
Substances
COVID-19 Vaccines
Grants and funding
Institut Pasteur
TheraVectys